Cargando…
Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis
BACKGROUND: Mass COVID-19 vaccination campaigns have helped impede the COVID-19 pandemic. In rare cases, some vaccines have led to vaccine associated myocarditis in a specific subset of the population, usually young males. Cardiac magnetic resonance (CMR) can reliably diagnose vaccine associated myo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682292/ https://www.ncbi.nlm.nih.gov/pubmed/36440045 http://dx.doi.org/10.3389/fcvm.2022.1049256 |
_version_ | 1784834819744595968 |
---|---|
author | Kravchenko, Dmitrij Isaak, Alexander Mesropyan, Narine Bischoff, Leon M. Pieper, Claus C. Attenberger, Ulrike Kuetting, Daniel Zimmer, Sebastian Hart, Christopher Luetkens, Julian A. |
author_facet | Kravchenko, Dmitrij Isaak, Alexander Mesropyan, Narine Bischoff, Leon M. Pieper, Claus C. Attenberger, Ulrike Kuetting, Daniel Zimmer, Sebastian Hart, Christopher Luetkens, Julian A. |
author_sort | Kravchenko, Dmitrij |
collection | PubMed |
description | BACKGROUND: Mass COVID-19 vaccination campaigns have helped impede the COVID-19 pandemic. In rare cases, some vaccines have led to vaccine associated myocarditis in a specific subset of the population, usually young males. Cardiac magnetic resonance (CMR) can reliably diagnose vaccine associated myocarditis, but follow-up data of CMR proven acute myocarditis is scarce. MATERIALS AND METHODS: Nine patients with acute vaccine associated myocarditis underwent baseline and follow-up CMR examinations and were compared to baseline parameters at initial presentation and to a group of 20 healthy controls. CMR protocol included functional assessment, T1 and T2 mapping, T2 signal intensity ratio, strain feature tracking, and late gadolinium enhancement (LGE). RESULTS: Myocarditis patients (n = 9, aged 24 ± 6 years, 8 males) underwent CMR follow-up after an average of 5.8 ± 4.3 months. All patients showed a complete resolution of visual myocardial edema while also demonstrating a reduction in overall LGE extent from baseline to follow-up (4.2 ± 2.1 vs. 0.9 ± 0.8%, p < 0.001), although visual LGE was still noted in all patients. Left ventricular ejection fraction was normal at baseline and at follow-up (58 ± 6 vs. 62 ± 4%, p = 0.10) as well as compared to a healthy control group (60 ± 4%, p = 0.24). T1 (1024 ± 77 vs. 971 ± 34 ms, p = 0.05) and T2 relaxations times (57 ± 6 vs. 51 ± 3 ms, p = 0.03) normalized at follow-up. Most patients reported a resolution of clinical symptoms, while two (22%) reported new onset of exertional dyspnea. CONCLUSION: Patients with COVID-19 vaccine associated acute myocarditis showed a complete, uncomplicated resolution of myocardial inflammation on follow-up CMR, which was associated with a near complete resolution of symptoms. Minor, residual myocardial scarring was present on follow-up LGE imaging. The long-term implications of the remaining myocardial scar-tissue after vaccine associated myocarditis remain unknown warranting further studies. |
format | Online Article Text |
id | pubmed-9682292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96822922022-11-24 Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis Kravchenko, Dmitrij Isaak, Alexander Mesropyan, Narine Bischoff, Leon M. Pieper, Claus C. Attenberger, Ulrike Kuetting, Daniel Zimmer, Sebastian Hart, Christopher Luetkens, Julian A. Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Mass COVID-19 vaccination campaigns have helped impede the COVID-19 pandemic. In rare cases, some vaccines have led to vaccine associated myocarditis in a specific subset of the population, usually young males. Cardiac magnetic resonance (CMR) can reliably diagnose vaccine associated myocarditis, but follow-up data of CMR proven acute myocarditis is scarce. MATERIALS AND METHODS: Nine patients with acute vaccine associated myocarditis underwent baseline and follow-up CMR examinations and were compared to baseline parameters at initial presentation and to a group of 20 healthy controls. CMR protocol included functional assessment, T1 and T2 mapping, T2 signal intensity ratio, strain feature tracking, and late gadolinium enhancement (LGE). RESULTS: Myocarditis patients (n = 9, aged 24 ± 6 years, 8 males) underwent CMR follow-up after an average of 5.8 ± 4.3 months. All patients showed a complete resolution of visual myocardial edema while also demonstrating a reduction in overall LGE extent from baseline to follow-up (4.2 ± 2.1 vs. 0.9 ± 0.8%, p < 0.001), although visual LGE was still noted in all patients. Left ventricular ejection fraction was normal at baseline and at follow-up (58 ± 6 vs. 62 ± 4%, p = 0.10) as well as compared to a healthy control group (60 ± 4%, p = 0.24). T1 (1024 ± 77 vs. 971 ± 34 ms, p = 0.05) and T2 relaxations times (57 ± 6 vs. 51 ± 3 ms, p = 0.03) normalized at follow-up. Most patients reported a resolution of clinical symptoms, while two (22%) reported new onset of exertional dyspnea. CONCLUSION: Patients with COVID-19 vaccine associated acute myocarditis showed a complete, uncomplicated resolution of myocardial inflammation on follow-up CMR, which was associated with a near complete resolution of symptoms. Minor, residual myocardial scarring was present on follow-up LGE imaging. The long-term implications of the remaining myocardial scar-tissue after vaccine associated myocarditis remain unknown warranting further studies. Frontiers Media S.A. 2022-11-09 /pmc/articles/PMC9682292/ /pubmed/36440045 http://dx.doi.org/10.3389/fcvm.2022.1049256 Text en Copyright © 2022 Kravchenko, Isaak, Mesropyan, Bischoff, Pieper, Attenberger, Kuetting, Zimmer, Hart and Luetkens. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Kravchenko, Dmitrij Isaak, Alexander Mesropyan, Narine Bischoff, Leon M. Pieper, Claus C. Attenberger, Ulrike Kuetting, Daniel Zimmer, Sebastian Hart, Christopher Luetkens, Julian A. Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis |
title | Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis |
title_full | Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis |
title_fullStr | Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis |
title_full_unstemmed | Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis |
title_short | Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis |
title_sort | cardiac magnetic resonance follow-up of covid-19 vaccine associated acute myocarditis |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682292/ https://www.ncbi.nlm.nih.gov/pubmed/36440045 http://dx.doi.org/10.3389/fcvm.2022.1049256 |
work_keys_str_mv | AT kravchenkodmitrij cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis AT isaakalexander cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis AT mesropyannarine cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis AT bischoffleonm cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis AT pieperclausc cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis AT attenbergerulrike cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis AT kuettingdaniel cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis AT zimmersebastian cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis AT hartchristopher cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis AT luetkensjuliana cardiacmagneticresonancefollowupofcovid19vaccineassociatedacutemyocarditis |